Lifeway Foods' Shares Rise 40% on Positive Q1 Sales Data with March Revenue Up 13% Y-O-Y
Source: Streetwise Reports  (4/15/20)
Shares of Lifeway Foods traded higher as the company reported it has increased production to support accelerated demand during the COVID-19 health crisis. More >

MEI Pharma Shares Rise 50% on $682.5M Partnership with Japanese Company to Treat B-cell Malignancies
Source: Streetwise Reports  (4/14/20)
Shares of MEI Pharma traded higher after the company announced that it has entered into development and global licensing agreement with Kyowa Kirin for its oral selective PI3Kδ inhibitor (ME-401) used for treating B-cell malignancies. More >

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19
Source: Streetwise Reports  (4/13/20)
Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. More >

Vir Partners with Samsung Biologics on Large-Scale Manufacture of COVID-19 Antibody Treatment
Source: Streetwise Reports  (4/10/20)
Vir Biotechnology reported it has entered into an agreement with Samsung Biologics valued at $362 million for large-scale manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Though U.S. markets are closed for the Good Friday holiday, Samsung Biologics shares traded nearly 17% higher today on the Korean Stock exchange. More >

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial
Source: Streetwise Reports  (4/9/20)
Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. More >

Company Secures Largest Order to Date for Antibiotic-Free Feedstock Supplement
Source: Streetwise Reports  (4/8/20)
Avivagen Inc. has secured its largest ever order of OxC-betaâ„¢ Livestock from its long-standing Philippine partner UNAHCO. More >

Biopharma's Technology Could Render Drug Suitable for COVID-19 Treatment
Source: Streetwise Reports  (4/8/20)
How this could be achieved using the proprietary platform of TFF Pharmaceuticals and why it could work are discussed in a ROTH Capital Partners report. More >

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May
Source: Streetwise Reports  (4/8/20)
Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expected in July 2020. More >

Telemedicine Platform Grows to More Than 100,000 Registered Users
Source: Streetwise Reports  (4/8/20)
CloudMD attributed record weekly new user registrations to social distancing protocols and advised that it now has greater than 100,000 registered users on its telemedicine platforms. More >

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data
Source: Streetwise Reports  (4/6/20)
Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. More >

Animal Feed Supplement Maker Expands Asia Footprint
Source: Streetwise Reports  (4/4/20)
Avivagen receives new orders from two eastern countries for its product. More >

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy
Source: Streetwise Reports  (4/3/20)
Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. More >

Three COVID-19 Patients Treated with PLX Cells
Source: Streetwise Reports  (4/1/20)
Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. More >

Healthcare Firm Expands Telemedicine App to Ontario as Coronavirus Concerns Accelerate Demand
Source: Streetwise Reports  (4/1/20)
CloudMD reported that it has launched its telemedicine app in Ontario as coronavirus concerns have greatly increased the need for digital healthcare. More >

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick
Source: Streetwise Reports  (4/1/20)
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. More >

Cannabis Beverage and Edibles Supplier Signs Agreements with Manitoba and Saskatchewan
Source: Streetwise Reports  (3/31/20)
Sproutly Canada's subsidiary company Toronto Herbal Remedies has entered into a cannabis supply contract with Manitoba and Saskatchewan provinces to carry the firm's CALIBER brand indoor-grown dried flower products. More >

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment
Source: Streetwise Reports  (3/31/20)
Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. More >

Abbott Labs Launches Point-of-Care Diagnostic Tool that Can Detect COVID-19 in 5 Minutes
Source: Streetwise Reports  (3/30/20)
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOWâ„¢ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day. More >

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug
Source: Streetwise Reports  (3/27/20)
Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. More >

Maker of Antibiotic-Free Animal Supplement Lands First Order from Mexico
Source: Streetwise Reports  (3/26/20)
This new market is a significant one for Avivagen. More >

Inhaled Nitric Oxide Being Tested as COVID-19 Treatment
Source: Streetwise Reports  (3/26/20)
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring. More >

Canadian Logistics Firm Partners with Cannabis Companies
Source: Streetwise Reports  (3/26/20)
ParcelPal Technology continues expanding its reach into this growing market. More >

Coronavirus Propels Telemedicine into the Spotlight
Source: McAlinden Research for Streetwise Reports  (3/26/20)
McAlinden Research Partners takes a look at how telemedicine companies are positioned to profit both during and in the wake of the current pandemic, and offers a couple of options for investors. More >

Digital Health Firm Expands Its Mobile Platform to Four U.S. States
Source: Streetwise Reports  (3/26/20)
Reliq Health Technologies has entered into an agreement with MedTech Evolutions to provide its iUGO Care platform to over 27,000 patients in Alabama, Illinois, Mississippi and Tennessee. More >

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus
Source: Streetwise Reports  (3/26/20)
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. More >